H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation

Zongkuo Li; Menglong Hu; Jinhuan Qiu; Junkai Feng; Ruizhen Zhang; Huifang Wu; Guiming Hu; Jingli Ren

doi:10.12659/MSM.933447

14 January 2022 : Database Analysis

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation

Zongkuo Li^12AE, Menglong Hu^12A, Jinhuan Qiu^12C, Junkai Feng^12C, Ruizhen Zhang^1C, Huifang Wu^1D, Guiming Hu^1D, Jingli Ren^1G*

DOI: 10.12659/MSM.933447

Med Sci Monit 2022; 28:e933447

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 Kaplan-Meier survival curves comparing the high and low expression of H2AFZ in TCGA-LUAD, GSE68465, and our cohorts. (A) Kaplan-Meier (KM) survival analysis of H2AFZ in LUAD based on the TCGA-LUAD cohort. (B) Kaplan-Meier (KM) survival analysis of H2AFZ in LUAD based on the GSE68465. (C) Kaplan-Meier (KM) survival analysis of H2AFZ in LUAD based on our cohort. GraphPad Prism 7.0 software (GraphPad Software Inc., La Jolla, CA, USA).

Back to the Article

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation

Your Privacy